Breaking Down Barriers to ADHD Treatment: A Game-Changer for Canberra Residents
Accessing ADHD medication just got a whole lot easier for Canberra residents. In a move that’s set to transform the way ADHD care is delivered, appropriately trained general practitioners (GPs) in the region can now prescribe ADHD medications without requiring repeated specialist reviews. But here’s where it gets even more impactful: this change not only streamlines the process but also addresses long-standing challenges faced by individuals and families living with ADHD.
For years, eligible patients had to endure the hassle of frequent reviews by psychiatrists, paediatricians, or neurologists just to continue their ADHD medication. Now, Canberra GPs who’ve completed approved training can take the reins, provided the patient is stable on their medication, is aged six or older, and has an existing specialist diagnosis. And this is the part most people miss—GPs won’t even need approval from the Chief Health Officer to continue prescribing, further cutting down on red tape.
Health Minister Rachel Stephen-Smith highlighted the dual benefits of this reform: ‘Families and individuals living with ADHD often face unnecessary hurdles in accessing treatment. These changes are the first step in our commitment to better ADHD care in the ACT, reducing delays and easing the burden on both patients and healthcare providers.’
But here’s where it gets controversial—while GPs gain more autonomy, specialists like psychiatrists, paediatricians, and neurologists will now need approval from the Chief Health Officer to prescribe ADHD medications within specific dosage ranges. Is this a necessary safeguard, or does it add another layer of complexity? We’d love to hear your thoughts in the comments.
The Australian Medical Association (AMA) ACT president, Dr. Kerrie Aust, praised the move as a ‘sensible reform’, noting it aligns with clinical realities and patient demands for better access to care. ‘This change maintains safeguards while recognizing GPs as central care providers,’ she added. Yet, some might argue whether GPs are fully equipped to handle ADHD care without specialist oversight. What do you think—is this a step forward or a potential oversight?
For those GPs not ready to expand their ADHD scope, a shared-care model with specialists remains an option. Meanwhile, the impact of this reform is hard to ignore, especially considering ADHD affects an estimated 6-10% of Australian children and young people, and 2-10% of adults. Dr. Rebekah Hoffman, chair of the Royal Australian College of GPs (RACGP) NSW&ACT, emphasized the tangible benefits: ‘This will significantly reduce wait times for specialist appointments, ensuring timely and consistent care for patients.’
Looking ahead, further reforms are on the horizon. Later this year, GPs with additional training will be able to diagnose ADHD and initiate medication, marking another leap in accessibility. ‘These changes will ease pressure on the health system while ensuring safe prescribing practices,’ said Ms. Stephen-Smith. But is this expansion of GP roles a welcome shift, or does it risk diluting specialized care? Let’s keep the conversation going.
Dr. Hoffman previously pointed out that GPs’ role in ADHD management was ‘overdue’, citing successful models in Queensland. ‘GPs are well-positioned to provide holistic, continuing care for ADHD patients,’ she argued. Yet, not everyone may agree. Do you think GPs can effectively manage ADHD, or should this remain a specialist domain?
As these changes roll out, one thing is clear: ADHD care in Canberra is entering a new era. For more information, visit the ACT Government’s website here or HealthDirect here. What’s your take on these reforms? Share your thoughts below—we’re all ears!
